Works by Grunberger, George

Results: 61
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    The Safety of Injecting Insulin Through Clothing.

    Published in:
    Diabetes Care, 1997, v. 20, n. 3, p. 244, doi. 10.2337/diacare.20.3.244
    By:
    • Fleming, Doris R.;
    • Jacober, Scott J.;
    • Vandenberg, Melissa A.;
    • Fitzgerald, James T.;
    • Grunberger, George
    Publication type:
    Article
    22
    23
    24
    25

    The reliability of the diabetes care profile for African...

    Published in:
    Evaluation & the Health Professions, 1998, v. 21, n. 1, p. 52, doi. 10.1177/016327879802100103
    By:
    • Fitzgerald, James T.;
    • Anderson, Robert M.;
    • Gruppen, Larry D.;
    • Davis, Wayne K.;
    • Aman, Linda C.;
    • Jacober, Scott J.;
    • Grunberger, George
    Publication type:
    Article
    26
    27
    28
    29

    Quo vadis diabetes technology?

    Published in:
    Journal of Czech Physicians / Časopis Lékařů Českých, 2017, v. 156, n. 6, p. 293
    By:
    • Grunberger, George
    Publication type:
    Article
    30
    31
    32
    33
    34

    Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel.

    Published in:
    American Journal of Health-System Pharmacy, 2013, v. 70, n. 16, p. 1404, doi. 10.2146/ajhp130169
    By:
    • COBAUGH, DANIEL J.;
    • MAYNARD, GREGORY;
    • COOPER, LEBRON;
    • KIENLE, PATRICIA C.;
    • VIGERSKY, ROBERT;
    • CHILDERS, DIANA;
    • WEBER, ROBERT;
    • CARSON, STACY L.;
    • MABREY, MELANIE E.;
    • RODERMAN, NICKI;
    • BLUM, FREDERICK;
    • BURKHOLDER, REBECCA;
    • DORTCH, MARCUS;
    • GRUNBERGER, GEORGE;
    • HAYS, DANIEL;
    • HENDERSON, RASHIDA;
    • KETZ, JEFFREY;
    • LEMKE, TODD;
    • VARMA, SURENDRA K.;
    • COHEN, MICHAEL
    Publication type:
    Article
    35
    36
    37
    38

    Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

    Published in:
    2019
    By:
    • Battelino, Tadej;
    • Danne, Thomas;
    • Bergenstal, Richard M.;
    • Amiel, Stephanie A.;
    • Beck, Roy;
    • Biester, Torben;
    • Bosi, Emanuele;
    • Buckingham, Bruce A.;
    • Cefalu, William T.;
    • Close, Kelly L.;
    • Cobelli, Claudio;
    • Dassau, Eyal;
    • DeVries, J. Hans;
    • Donaghue, Kim C.;
    • Dovc, Klemen;
    • Doyle III, Francis J.;
    • Garg, Satish;
    • Grunberger, George;
    • Heller, Simon;
    • Heinemann, Lutz
    Publication type:
    journal article
    39

    International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

    Published in:
    2019
    By:
    • Danne, Thomas;
    • Garg, Satish;
    • Peters, Anne L.;
    • Buse, John B.;
    • Mathieu, Chantal;
    • Pettus, Jeremy H.;
    • Alexander, Charles M.;
    • Battelino, Tadej;
    • Ampudia-Blasco, F. Javier;
    • Bode, Bruce W.;
    • Cariou, Bertrand;
    • Close, Kelly L.;
    • Dandona, Paresh;
    • Dutta, Sanjoy;
    • Ferrannini, Ele;
    • Fourlanos, Spiros;
    • Grunberger, George;
    • Heller, Simon R.;
    • Henry, Robert R.;
    • Kurian, Martin J.
    Publication type:
    journal article
    40
    41
    42

    Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

    Published in:
    2017
    By:
    • Rosenstock, Julio;
    • Aronson, Ronnie;
    • Grunberger, George;
    • Hanefeld, Markolf;
    • Piatti, PierMarco;
    • Serusclat, Pierre;
    • Cheng, Xi;
    • Zhou, Tianyue;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Davies, Melanie;
    • LixiLan-O Trial Investigators
    Publication type:
    journal article
    43

    Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.

    Published in:
    2016
    By:
    • Rosenstock, Julio;
    • Aronson, Ronnie;
    • Grunberger, George;
    • Hanefeld, Markolf;
    • Piatti, PierMarco;
    • Serusclat, Pierre;
    • Xi Cheng;
    • Tianyue Zhou;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Davies, Melanie;
    • Cheng, Xi;
    • Zhou, Tianyue;
    • LixiLan-O Trial Investigators
    Publication type:
    journal article
    44

    Statement of Principle.

    Published in:
    Diabetes Care, 2015, v. 38, n. 1, p. 176, doi. 10.2337/dc14-sp01
    By:
    • Cefalu, William T.;
    • Nair, K. Sreekumaran;
    • Seaquist, Elizabeth R.;
    • Zierath, Juleen;
    • Boulton, Andrew J.M.;
    • LeRoith, Derek;
    • Harrell, R. Mack;
    • Grunberger, George;
    • Wartofsky, Leonard;
    • Gore, Andrea C.;
    • Wierman, Margaret;
    • Hammes, Stephen R.;
    • Lange, Carol A.;
    • Santen, Richard J.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50